| P50 | author | Atsushi Tanaka | Q87020987 |
| P2093 | author name string | Masashi Fukayama | |
| | Keisuke Matsusaka | |
| | Akiko Kunita | |
| | Takeshi Sasaki | |
| | Yasuyuki Seto | |
| | Keiichiro Tada | |
| | Masako Ikemura | |
| | Kazutaka Otsuji | |
| P2860 | cites work | Digital PCR | Q24685020 |
| | HER2 in situ hybridization in breast cancer: clinical implications of polysomy 17 and genetic heterogeneity | Q27006811 |
| | High-throughput droplet digital PCR system for absolute quantitation of DNA copy number | Q28251729 |
| | Optimization of Droplet Digital PCR from RNA and DNA extracts with direct comparison to RT-qPCR: Clinical implications for quantification of Oseltamivir-resistant subpopulations. | Q30378470 |
| | Determination of HER2 amplification status on tumour DNA by digital PCR | Q35080338 |
| | Tumor Content Chart-Assisted HER2/CEP17 Digital PCR Analysis of Gastric Cancer Biopsy Specimens. | Q36000688 |
| | Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation | Q36008206 |
| | MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma | Q36544390 |
| | American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer | Q36678853 |
| | Assessment of a HER2 scoring system for gastric cancer: results from a validation study | Q37142266 |
| | Development of DNA damage response signaling biomarkers using automated, quantitative image analysis | Q37604397 |
| | Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer | Q37613953 |
| | Current technologies for HER2 testing in breast cancer. | Q37832859 |
| | Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17. | Q38414983 |
| | Fluorescence in situ hybridization (FISH) as primary methodology for the assessment of HER2 Status in adenocarcinoma of the breast: a single institution experience | Q38459417 |
| | Noninvasive detection of HER2 amplification with plasma DNA digital PCR. | Q40108755 |
| | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | automation | Q184199 |
| | droplet digital PCR | Q112144033 |
| P304 | page(s) | 11-18 | |
| P577 | publication date | 2016-12-30 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Use of droplet digital PCR for quantitative and automatic analysis of the HER2 status in breast cancer patients | |
| P478 | volume | 162 | |